Specific Biologics Inc.
- Biotech or pharma, therapeutic R&D
Specific Biologics is developing Dualase®, an industry-leading genome editing platform with best-in-class accurate editing efficiency, undetectable off-target effects, and true plug-and-play programmability with broad therapeutic potential.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}